{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:42:01Z","timestamp":1791276121934,"version":"4.1.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Introduction: Hypophosphatasia (HPP) is the inborn error of metabolism that features rickets or osteomalacia caused by loss-of-function mutation(s) within the gene that encodes the tissue-nonspecific isozyme of alkaline phosphatase (TNALP). Consequently, natural substrates for this ectoenzyme accumulate extracellulary including inorganic pyrophosphate (PPi), an inhibitor of mineralization, and pyridoxal 5\u2032-phosphate (PLP), a co-factor form of vitamin B6. Babies with the infantile form of HPP often die with severe rickets and sometimes hypercalcemia and vitamin B6-dependent seizures. There is no established medical treatment.<\/jats:p>\n                  <jats:p>Materials and Methods: Human TNALP was bioengineered with the C terminus extended by the Fc region of human IgG for one-step purification and a deca-aspartate sequence (D10) for targeting to mineralizing tissue (sALP-FcD10). TNALP-null mice (Akp2\u2212\/\u2212), an excellent model for infantile HPP, were treated from birth using sALP-FcD10. Short-term and long-term efficacy studies consisted of once daily subcutaneous injections of 1, 2, or 8.2 mg\/kg sALP-FcD10 for 15, 19, and 15 or 52 days, respectively. We assessed survival and growth rates, circulating levels of sALP-FcD10 activity, calcium, PPi, and pyridoxal, as well as skeletal and dental manifestations using radiography, \u03bcCT, and histomorphometry.<\/jats:p>\n                  <jats:p>Results: Akp2 \u2212\/\u2212 mice receiving high-dose sALP-FcD10 grew normally and appeared well without skeletal or dental disease or epilepsy. Plasma calcium, PPi, and pyridoxal concentrations remained in their normal ranges. We found no evidence of significant skeletal or dental disease.<\/jats:p>\n                  <jats:p>Conclusions: Enzyme replacement using a bone-targeted, recombinant form of human TNALP prevents infantile HPP in Akp2\u2212\/\u2212 mice.<\/jats:p>","DOI":"10.1359\/jbmr.071213","type":"journal-article","created":{"date-parts":[[2007,12,17]],"date-time":"2007-12-17T13:27:02Z","timestamp":1197898022000},"page":"777-787","source":"Crossref","is-referenced-by-count":228,"title":["Enzyme Replacement Therapy for Murine Hypophosphatasia"],"prefix":"10.1093","volume":"23","author":[{"given":"Jos\u00e9 Luis","family":"Mill\u00e1n","sequence":"first","affiliation":[{"name":"Burnham Institute for Medical Research, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonoko","family":"Narisawa","sequence":"additional","affiliation":[{"name":"Burnham Institute for Medical Research, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lemire","sequence":"additional","affiliation":[{"name":"Enobia Pharma, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P","family":"Loisel","sequence":"additional","affiliation":[{"name":"Enobia Pharma, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Boileau","sequence":"additional","affiliation":[{"name":"University of Montreal, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Leonard","sequence":"additional","affiliation":[{"name":"Enobia Pharma, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Gramatikova","sequence":"additional","affiliation":[{"name":"Burnham Institute for Medical Research, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Terkeltaub","sequence":"additional","affiliation":[{"name":"VAMC\/UCSD, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Pleshko","family":"Camacho","sequence":"additional","affiliation":[{"name":"The Hospital for Special Surgery, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc D","family":"McKee","sequence":"additional","affiliation":[{"name":"McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Crine","sequence":"additional","affiliation":[{"name":"Enobia Pharma, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P","family":"Whyte","sequence":"additional","affiliation":[{"name":"Shriners Hospitals for Children and Washington University, St Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024020319530094900_bib1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archpedi.1948.02030020840003","article-title":"Hypophosphatasia, a new developmental anomaly","volume":"75","author":"Rathbun","year":"1948","journal-title":"Am J Dis Child"},{"key":"2024020319530094900_bib2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/0002-9343(57)90124-9","article-title":"Hypophosphatasia","volume":"22","author":"Fraser","year":"1957","journal-title":"Am J Med"},{"key":"2024020319530094900_bib3","first-page":"439","article-title":"Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization","volume":"15","author":"Whyte","year":"1994","journal-title":"Endocr Rev"},{"key":"2024020319530094900_bib4","first-page":"5313","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Whyte","year":"2001"},{"key":"2024020319530094900_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/geno.1993.1305","article-title":"A homoallelic Gly317\u2192Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites","volume":"17","author":"Greenberg","year":"1993","journal-title":"Genomics"},{"key":"2024020319530094900_bib6","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1073\/pnas.85.20.7666","article-title":"A missense mutation in the human liver\/bone\/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia","volume":"85","author":"Weiss","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024020319530094900_bib7","doi-asserted-by":"crossref","first-page":"9924","DOI":"10.1073\/pnas.89.20.9924","article-title":"Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia","volume":"89","author":"Henthorn","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024020319530094900_bib8","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/clinchem\/38.12.2501","article-title":"Missense mutations of the tissue-nonspecific alkaline phosphatase gene in hypophosphatasia","volume":"38","author":"Henthorn","year":"1992","journal-title":"Clin Chem"},{"key":"2024020319530094900_bib9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/hmg\/8.6.1039","article-title":"Correlations of genotype and phenotype in hypophosphatasia","volume":"8","author":"Zurutuza","year":"1999","journal-title":"Hum Mol Genet"},{"key":"2024020319530094900_bib10","volume-title":"From Biology to Applications in Medicine and Biotechnology","author":"Mill\u00e1n","year":"2006"},{"key":"2024020319530094900_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ng0995-45","article-title":"Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6","volume":"11","author":"Waymire","year":"1995","journal-title":"Nat Genet"},{"key":"2024020319530094900_bib12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1","article-title":"Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia","volume":"208","author":"Narisawa","year":"1997","journal-title":"Dev Dyn"},{"key":"2024020319530094900_bib13","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1359\/jbmr.1999.14.12.2015","article-title":"Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia","volume":"14","author":"Fedde","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024020319530094900_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH722>3.0.CO;2-Y","article-title":"Abnormal vitamin B6 metabolism in alkaline phosphatase knockout mice causes multiple abnormalities, but not the impaired bone mineralization","volume":"193","author":"Narisawa","year":"2001","journal-title":"J Pathol"},{"key":"2024020319530094900_bib15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1073\/pnas.67.3.1513","article-title":"Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage","volume":"67","author":"Ali","year":"1970","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024020319530094900_bib16","first-page":"218","article-title":"Ultrastructural localization of alkaline phosphatase in initial intramembranous osteogenesis","volume":"135","author":"Bernard","year":"1978","journal-title":"Clin Orthop"},{"key":"2024020319530094900_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0169-6009(92)90877-G","article-title":"Immunolocalization of alkaline phosphatase in osteoblasts and matrix vesicles of human fetal bone","volume":"19","author":"Morris","year":"1992","journal-title":"Bone Miner"},{"key":"2024020319530094900_bib18","first-page":"1555","article-title":"Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals","volume":"151","author":"Anderson","year":"1997","journal-title":"Am J Pathol"},{"key":"2024020319530094900_bib19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0002-9440(10)63172-0","article-title":"Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice","volume":"164","author":"Anderson","year":"2004","journal-title":"Am J Pathol"},{"key":"2024020319530094900_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9861(84)90356-4","article-title":"Can biological calcification occur in the presence of pyrophosphate?","volume":"231","author":"Meyer","year":"1984","journal-title":"Arch Biochem Biophys"},{"key":"2024020319530094900_bib21","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1073\/pnas.142063399","article-title":"Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization","volume":"99","author":"Hessle","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024020319530094900_bib22","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0002-9440(10)63208-7","article-title":"Concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp1, and Ank: An integrated model of the pathogenesis of mineralization disorders","volume":"164","author":"Harmey","year":"2004","journal-title":"Am J Pathol"},{"key":"2024020319530094900_bib23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1101\/gad.1276205","article-title":"Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone","volume":"19","author":"Murshed","year":"2005","journal-title":"Genes Dev"},{"key":"2024020319530094900_bib24","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1359\/jbmr.060619","article-title":"Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2\u2212\/\u2212 mice","volume":"21","author":"Harmey","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2024020319530094900_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-3476(82)80061-9","article-title":"Infantile hypophosphatasia: Enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone disease","volume":"101","author":"Whyte","year":"1982","journal-title":"J Pediatr"},{"key":"2024020319530094900_bib26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3476(84)80079-7","article-title":"Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: Results in three additional patients","volume":"105","author":"Whyte","year":"1984","journal-title":"J Pediatr"},{"key":"2024020319530094900_bib27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1651-2227.1989.tb11297.x","article-title":"Biochemical and morphological effects of human hepatic alkaline phosphatase in a neonate with hypophosphatasia","volume":"360","author":"Weninger","year":"1989","journal-title":"Acta Paediatr Scand Suppl"},{"issue":"S2","key":"2024020319530094900_bib28","first-page":"S155","article-title":"Failure of hyperphosphatasemia by intravenous infusion of purified placental alkaline phosphatase (ALP) to correct severe hypophosphatasia: Evidence against a role for circulating ALP in skeletal mineralization","volume":"7","author":"Whyte","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2024020319530094900_bib29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1359\/jbmr.2003.18.4.624","article-title":"Marrow cell transplantation for infantile hypophosphatasia","volume":"18","author":"Whyte","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2024020319530094900_bib30","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1210\/jc.2006-2131","article-title":"Infantile hypophosphatasia: Transplantation therapy trial using bone fragments and cultured osteoblasts","volume":"92","author":"Cahill","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319530094900_bib31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0092-8674(83)90422-1","article-title":"Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells","volume":"33","author":"Urlaub","year":"1983","journal-title":"Cell"},{"key":"2024020319530094900_bib32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1359\/jbmr.1999.14.6.883","article-title":"Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells","volume":"14","author":"Johnson","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024020319530094900_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-4347(92)80223-D","article-title":"Determination of vitamin B6 vitamers and pyridoxic acid in biological samples","volume":"578","author":"Sharma","year":"1992","journal-title":"J Chromatogr A"},{"key":"2024020319530094900_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0009-8981(73)90101-0","article-title":"Direct microdetermination of serum calcium","volume":"46","author":"Baginski","year":"1973","journal-title":"Clin Chim Acta"},{"key":"2024020319530094900_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/aja.1002010306","article-title":"Stage-specific expression of alkaline phosphatase during neural development in the mouse","volume":"201","author":"Narisawa","year":"1994","journal-title":"Dev Dyn"},{"key":"2024020319530094900_bib36","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1359\/jbmr.2002.17.8.1383","article-title":"Kinetic characterization of hypophosphatasia mutations with physiological substrates","volume":"17","author":"Di Mauro","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024020319530094900_bib37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymgme.2006.02.012","article-title":"Enhancement of drug delivery to bone: Characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide","volume":"88","author":"Nishioka","year":"2006","journal-title":"Mol Genet Metab"},{"key":"2024020319530094900_bib38","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1177\/00220345990780060501","article-title":"Root development in mice lacking functional tissue non-specific alkaline phosphatase gene: Inhibition of acellular cementum formation","volume":"78","author":"Beertsen","year":"1999","journal-title":"J Dent Res"},{"key":"2024020319530094900_bib39","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/154405910508401110","article-title":"Cementum and dentin in hypophosphatasia","volume":"84","author":"Van den Bos","year":"2005","journal-title":"J Dent Res"},{"key":"2024020319530094900_bib40","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0002-9440(10)62481-9","article-title":"Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase\/nucleotide pyrophosphatase phosphodiesterase 1 double deficient mice","volume":"166","author":"Anderson","year":"2005","journal-title":"Am J Pathol"},{"key":"2024020319530094900_bib41","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bone.2007.01.020","article-title":"Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T&gt;C, p.M226T; c.1112C&gt;T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene","volume":"40","author":"Baumgartner-Sigl","year":"2007","journal-title":"Bone"},{"key":"2024020319530094900_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1043-4526(08)60023-6","article-title":"Modeling vitamin B6 metabolism","volume":"40","author":"Coburn","year":"1996","journal-title":"Adv Food Nutr Res"},{"key":"2024020319530094900_bib43","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0959-440X(98)80096-1","article-title":"Structure, evolution and action of vitamin B6-dependent enzymes","volume":"8","author":"Jansonius","year":"1998","journal-title":"Curr Opin Struct Biol"},{"key":"2024020319530094900_bib44","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI112031","article-title":"Markedly increased circulating pyridoxal-5\/-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism","volume":"76","author":"Whyte","year":"1985","journal-title":"J Clin Invest"},{"key":"2024020319530094900_bib45","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1172\/JCI113440","article-title":"Perinatal hypophosphatasia: Tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5\/-phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase","volume":"81","author":"Whyte","year":"1988","journal-title":"J Clin Invest"},{"key":"2024020319530094900_bib46","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1172\/JCI117814","article-title":"Alkaline phosphatase: Placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5\u2032-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy","volume":"95","author":"Whyte","year":"1995","journal-title":"J Clin Invest"},{"key":"2024020319530094900_bib47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1042\/bj0170286","article-title":"The possible significance of hexosephosphoric esters in ossification","volume":"17","author":"Robison","year":"1923","journal-title":"Biochem J"},{"key":"2024020319530094900_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0005-2744(75)90151-5","article-title":"Studies on matrix vesicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase","volume":"391","author":"Majeska","year":"1975","journal-title":"Biochim Biophys Acta"},{"key":"2024020319530094900_bib49","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4613-2970-1","volume-title":"Alkaline Phosphatase","author":"McComb","year":"1979"},{"key":"2024020319530094900_bib50","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jbmr.5650100409","article-title":"The phosphatidylinositol-glycolipid anchor on alkaline phosphatase facilitates mineralization initiation in vitro","volume":"10","author":"Harrison","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2024020319530094900_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/bj1020053","article-title":"Association of inorganic-pyrophosphatase activity with human alkaline-phosphatase preparations","volume":"102","author":"Moss","year":"1967","journal-title":"Biochem J"},{"key":"2024020319530094900_bib52","first-page":"293","article-title":"Inorganic pyrophosphate-phosphohydrolytic activity associated with rat osseous plate alkaline phosphatase","volume":"44","author":"Rezende","year":"1998","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"2024020319530094900_bib53","doi-asserted-by":"crossref","first-page":"14368","DOI":"10.1016\/S0021-9258(18)68229-8","article-title":"The solubilization of tetrameric alkaline phosphatase from human liver and its conversion into various forms by phosphatidylinositol phospholipase C or proteolysis","volume":"263","author":"Hawrylak","year":"1988","journal-title":"J Biol Chem"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.071213","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/23\/6\/777\/56570781\/5650230602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/23\/6\/777\/56570781\/5650230602.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:50:14Z","timestamp":1710327014000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/23\/6\/777-787\/7599503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,1]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[2008,6,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.071213","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1120133.576279","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,6,1]]},"published":{"date-parts":[[2008,6,1]]}}}